The following table provides an overview of the latest patents of Prothera Biologics, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2945962Apr 17, 2019Methods For Isolating Blood Products From An Inter-Alpha Inhibitor Protein-Depleted Blood Product Material1